Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep

被引:32
作者
Maudhuit, C
Jolas, T
Chastanet, M
Hamon, M
Adrien, J
机构
[1] INSERM U288, CHU Pitié-Salpêtriere, Paris
[2] INSERM U288, CHU Pitié, Salpêtriere, 75634 Paris Cedex 13, 91, Bd de l'Hôpital
关键词
REM sleep deprivation; serotonin; 5-HT1A autoreceptor desensitization;
D O I
10.1016/0006-3223(95)00583-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies showed that chronic deprivation of rapid eye movement (REM) sleep had the same behavioral effects as antidepressant drugs in helpless rats. Since long-term treatment with antidepressants is known to affect central serotoninergic neurotransmission, we investigated whether REM sleep deprivation also exerts an influence on the activity of seratoninergic neurons within the dorsal raphe nucleus (DRN) in rats. REM sleep deprivation,cas performed using the platform technique. Recording of seratoninergic neurons in the DRN revealed no difference in the basal firing rate, but a reduced inhibitory response to the selective serotonin (5-HT) reuptake blockers cericlamine and citalopram after repeated but not acute REM sleep deprivation. These observations suggest that REM sleep deprivation renders serotoninergic DRN neurons less sensitive to the inhibitory effect of 5-HT reuptake blockers, probably because of functional desensitization of somatodendritic 5-HT1A autoreceptors, like that previously reported after chronic treatment with several antidepressants. Accordingly, REM sleep deprivation might alleviate depression through neurophysiological mechanisms similar to those induced by antidepressants. (C) 1996 Society of Biological Psychiatry
引用
收藏
页码:1000 / 1007
页数:8
相关论文
共 32 条
[11]   EFFECTS OF SINGLE AND CHRONIC TREATMENT WITH TRANYLCYPROMINE ON EXTRACELLULAR SEROTONIN IN RAT-BRAIN [J].
FERRER, A ;
ARTIGAS, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (03) :227-234
[12]  
Fornal C. A., 1994, British Journal of Pharmacology, V112, p92P
[13]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[14]   RELATIONSHIP BETWEEN CHANGES IN REM-SLEEP AND CLINICAL IMPROVEMENT IN DEPRESSED-PATIENTS TREATED WITH AMITRIPTYLINE [J].
GILLIN, JC ;
WYATT, RJ ;
FRAM, D ;
SNYDER, F .
PSYCHOPHARMACOLOGY, 1978, 59 (03) :267-272
[15]   INCREASED SYNTHESIS AND UTILIZATION OF SEROTONIN IN CENTRAL NERVOUS SYSTEM OF RAT DURING PARADOXICAL SLEEP DEPRIVATION [J].
HERY, F ;
PUJOL, JF ;
LOPEZ, M ;
MACON, J ;
GLOWINSKI, J .
BRAIN RESEARCH, 1970, 21 (03) :391-+
[16]  
JOLAS T, 1994, J PHARMACOL EXP THER, V268, P1432
[17]   EARLY DESENSITIZATION OF SOMATO-DENDRITIC 5-HT1A AUTORECEPTORS IN RATS TREATED WITH FLUOXETINE OR PAROXETINE [J].
LEPOUL, E ;
LAARIS, N ;
DOUCET, E ;
LAPORTE, AM ;
HAMON, M ;
LANFUMEY, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (02) :141-148
[18]   ELECTROPHYSIOLOGICAL ACTIVITY OF RAPHE DORSALIS SEROTONINERGIC NEURONS IN A POSSIBLE MODEL OF ENDOGENOUS-DEPRESSION [J].
MAUDHUIT, C ;
HAMON, M ;
ADRIEN, J .
NEUROREPORT, 1995, 6 (04) :681-684
[19]   EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH AMOXAPINE AND CERICLAMINE ON THE SLEEP-WAKEFULNESS CYCLE IN THE RAT [J].
MAUDHUIT, C ;
JOLAS, T ;
LAINEY, E ;
HAMON, M ;
ADRIEN, J .
NEUROPHARMACOLOGY, 1994, 33 (08) :1017-1025
[20]  
MICHEL F, 1961, CR SOC BIOL, V155, P2389